MedTrace Logo

Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder

NCT05034276 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2023-07-20

Study results available
· View outcomes & findings →

Summary

This is a Phase 1 trial that aims to establish the safety of MORE-VR, as well as to collect feasibility, usability, and engagement data, for patients receiving medications for opioid use disorder (mOUD).

Conditions

  • Opioid-use Disorder

Interventions

OTHER

MORE-VR

Mindfulness-Oriented Recovery Enhancement therapy delivered over virtual reality.

Sponsors & Collaborators

  • BehaVR LLC

    collaborator INDUSTRY

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Utah

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-04
Primary Completion
2022-04-01
Completion
2022-07-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05034276 on ClinicalTrials.gov